Showing Results for
- Academic Journals (27)
Search Results
- 27
Academic Journals
- 27
- Search Terms:
- 1From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedDiabetes mellitus is a serious, chronic medical condition that affects an estimated 20.8 million people in the United States. (1) Up to one third of people are undiagnosed. There were also an estimated 1.5 million new...
- 2From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedThe federal government in late March declared that solid organ transplantation centers participating in the Medicare program must have a multidisciplinary care team, but the agency in charge refused to require the...
- 3From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. To evaluate potential cost savings, trial data were used to determine the clinical outcomes for i.v. ertapenem given once daily and i.v. piperacillin-tazobactam given every six hours daily in treating diabetic...
- 4From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedAnna Mae Liuzza Cisneros, 84, died April 4 in a hospice facility in her native New Orleans. She had lung cancer and had endured Hurricane Katrina. Cisneros, along with her father, Pascal J. Liuzza, were charter members...
- 5From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedMy name is Azadeh. In Farsi, my m native tongue, it translates as one who is free." I was born to Iranian parents, Elyahoo and Nasrine Sabi, both from Jewish ancestry. My father converted to Christianity in his early...
- 6From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedAfter watching fellow members of my pharmacy residency class accept pharmacist positions, I realized the wide variety of career options available to pharmacists, from clinical specialist positions with minimal teaching...
- 7From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedProtein C concentrate (human) lyophilized powder for solution for injection (Ceprotin, Baxter): The human plasma-derived product is indicated as a replacement therapy for pediatric and adult patients with severe...
- 8From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-Reviewed********** Purpose. Recommendations for target blood glucose concentrations; factors that can complicate glycemic control; considerations that determine the aggressiveness of therapy to manage blood glucose levels; the...
- 9From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. The effectiveness of a pharmacy-obtained medication history on the medication reconciliation process in the behavioral health unit (BHU) of a community hospital was studied. Methods. Patients admitted to the...
- 10From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedRear Admiral John Babb, an officer in the U.S. Public Health Service (PHS) Commissioned Corps, has had a unique career since graduating pharmacy school nearly 40 years ago. He is the only pharmacist to have held three...
- 11From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedWith the acquisition of Schering AG complete, Bayer AG in April launched Bayer HealthCare Pharmaceuticals Inc. as the U.S.-based pharmaceuticals unit. The new company has its headquarters in Wayne, New Jersey, and...
- 12From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. An inpatient pneumococcal polysaccharide vaccine (PPV) vaccination program was designed and implemented to meet federal and state regulatory requirements and national vaccination goals. Summary. In 2002, the...
- 13From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. To evaluate the effectiveness of budesonide inhalation suspension relative to other common asthma therapies in a high-risk population, a study was conducted to compare the risk of having a repeat asthma-related...
- 14From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedNonsteroidal antiinflammatory drugs (NSAIDs) are modestly effective at best for relieving pain in patients with arthritis, said David Felson, professor of medicine and public health at Boston University School of...
- 15From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedHyperglycemia in hospitalized patients with and without diabetes has been the focus of recent attention because it increases morbidity, mortality, and costs. (1) Hyperglycemia causes problems with tissue and organ...
- 16From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. The stability of extemporaneously prepared phenylephrine hydrochloride injection stored in polypropylene syringes was studied. Methods. Dilution of phenylephrine hydrochloride to a nominal concentration of 100...
- 17From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedThe Department of Health and Human Services recently exercised its option with HealthCare Purchasing Partners International to extend the prime vendor contract for the 340B drug-pricing program. This one-year extension...
- 18From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedMax (Mick) L. Hunt Jr., M.S., M.B.A., FASHP, was promoted to Vice President of Pharmacy, Novation, Irving, Texas; previously he was senior director of pharmacy services....
- 19From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedPurpose. This article identifies approaches for implementing an inpatient anticoagulation program involving pharmacists; two successful inpatient anticoagulation programs previously reported in the literature are...
- 20From: American Journal of Health-System Pharmacy. (Vol. 64, Issue 10) Peer-ReviewedA finding of an increased risk of serious cardiovascular adverse events with short-term use of tegaserod prompted FDA in late March to ask Novartis to stop selling the serotonin type 4-receptor partial agonist....